Vl. Lanchote et al., INFLUENCE OF RENAL-FAILURE ON CYTOCHROME-P-450 ACTIVITY IN HYPERTENSIVE PATIENTS USING A COCKTAIL OF ANTIPYRINE AND NIFEDIPINE, European Journal of Clinical Pharmacology, 50(1-2), 1996, pp. 83-89
Objective. Two substrates were coadministered in a ''cocktail'' approa
ch to evaluate the contribution of renal failure to drug oxidation. Pa
tients. Nineteen hypertensive patients, nine of them with chronic rena
l failure (CL(CR) 38.9 vs 102.3 ml . min(-1). 1.73 m(-2)), were invest
igated after peroral administration of a combination of antipyrine (50
0 mg, in capsules) and nifedipine (10 mg, in Oxcord capsules) in the m
orning after an overnight fast. Results. This ''cocktail'' approach ma
de it possible to characterize in vivo the activities of different for
ms of cytochrome P-450 in a single-study protocol using the total clea
rance of nifedipine and clearance for production of 3-hydroxymethylant
ipyrine (HMA), 4-hydroxyantipyrine (OHA) and norantipyrine (NORA). Wit
h this ''cocktail'' approach (antipyrine plus nifedipine), we can sugg
est a selective effect on the activities of cytochrome P-450 forms ass
ociated with the formation of dehydronifedipine (P-450 III A(4)) and o
f NORA in patients with mild renal failure under long-term antihyperte
nsive therapy.